Q: You previously talked about drugs with pass-through status beginning in April, but are there any other items with changes in the OPPS update?
This week’s note is about the IPPS proposed rule.
This week’s updates include quarterly announcement of interest rate change; long term care and IPPS reclassification interim final rule; and more!
Q: What should the utilization review committee look for when an inpatient stay is less than two midnights?
Q: What should case managers do when a patient lacks decision-making capacity but has no guardian or power of attorney?
Q: Our pharmacy is asking if there is going to be payment for a new anti-hemophilia factor called Nuwiq. They say it is quite expensive and they want to know if there is additional payment for it.
